Advertisement

Topics

Cerebain Biotech Engages NMS Capital Advisors

08:30 EST 9 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Cerebain Biotech Corp. (“Cerebain” or “Company”) (OTCQB: CBBT), a development-stage medical device company focused on the creation and clinical development of a minimally invasive implantable device to address dementias,...

Other Sources for this Article

Cerebain Biotech Corp.
Investors:
Mr. Alan Klitenic, 888-430-2221
info@cerebain.com

NEXT ARTICLE

More From BioPortfolio on "Cerebain Biotech Engages NMS Capital Advisors"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...